Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The melanocortin receptors (MCRs) are a family of five closely related G protein-coupled receptors (GPCRs): MC1R, MC2R, MC3R, MC4R, and MC5R. These receptors play crucial roles in various physiological processes including pigmentation, energy homeostasis, inflammation regulation, and exocrine secretion. Each receptor subtype has distinct tissue distribution and functional roles. They are targets for drugs treating conditions such as obesity/metabolic syndrome (mainly MC4R) and pigmentation disorders/melanoma risk (mainly MC1R). Developing highly selective ligands is challenging due to high sequence conservation among receptor subtypes' ligand-binding regions. Structure-based drug design efforts focus on exploiting subtle differences between subtypes.
Agonists or antagonists binding to melanocortin receptors modulate cAMP levels and downstream signaling pathways, affecting pigmentation, energy balance, and other physiological processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanocortin Receptor (MCR).